• 1. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 2. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 3. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 4. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 5. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylmethylamines

Introduction to (2,6-difluorophenyl)methyl(propyl)amine (CAS No. 62924-68-9)

(2,6-difluorophenyl)methyl(propyl)amine, identified by its Chemical Abstracts Service (CAS) number 62924-68-9, is a fluorinated aromatic amine that has garnered significant attention in the field of pharmaceutical and chemical research. This compound, characterized by its dual fluorine substituents on the phenyl ring and a propylamine side chain, exhibits unique chemical properties that make it a valuable intermediate in the synthesis of various bioactive molecules.

The structural features of (2,6-difluorophenyl)methyl(propyl)amine contribute to its versatility in medicinal chemistry. The presence of fluorine atoms at the 2 and 6 positions of the phenyl ring enhances its lipophilicity and metabolic stability, which are critical factors in drug design. Additionally, the propylamine moiety introduces basicity and potential hydrogen bonding capabilities, making it a useful building block for developing pharmacologically active compounds.

In recent years, there has been a growing interest in fluorinated amines due to their role in enhancing drug efficacy and bioavailability. Studies have demonstrated that fluorine substitution can modulate the electronic properties of aromatic rings, leading to improved binding affinity and selectivity. This has been particularly evident in the development of kinase inhibitors and other targeted therapies, where fluorinated amines have shown promise in preclinical studies.

One of the most compelling applications of (2,6-difluorophenyl)methyl(propyl)amine is in the synthesis of small-molecule drugs that interact with biological targets. For instance, researchers have leveraged this compound to develop novel inhibitors of enzymes involved in cancer metabolism. The fluorine atoms improve the compound's interaction with target proteins by increasing its hydrophobicity and reducing susceptibility to enzymatic degradation. Furthermore, the propylamine group allows for further functionalization, enabling the creation of derivatives with enhanced pharmacokinetic profiles.

The pharmaceutical industry has also explored the use of (2,6-difluorophenyl)methyl(propyl)amine in the development of antiviral and antibacterial agents. Its structural motif has been incorporated into molecules designed to disrupt viral replication cycles or inhibit bacterial enzymes essential for survival. Preliminary findings suggest that compounds derived from this intermediate exhibit promising activity against resistant strains of pathogens, highlighting its potential as a scaffold for future therapeutic agents.

From a synthetic chemistry perspective, (2,6-difluorophenyl)methyl(propyl)amine offers a unique platform for exploring new reaction pathways and methodologies. The combination of fluorinated aromatic rings and primary amines provides opportunities for diverse functional group transformations, including nucleophilic substitutions, cross-coupling reactions, and cyclizations. These reactions are pivotal in constructing complex molecular architectures required for advanced drug discovery programs.

The chemical stability of this compound under various conditions has been thoroughly investigated. Studies have shown that (2,6-difluorophenyl)methyl(propyl)amine remains stable under standard storage conditions but may require specific handling protocols when exposed to strong acids or bases. Its solubility profile also varies depending on the solvent system used, which is an important consideration for both laboratory-scale synthesis and industrial production.

In conclusion, (2,6-difluorophenyl)methyl(propyl)amine (CAS No. 62924-68-9) is a multifaceted compound with significant potential in pharmaceutical research and development. Its unique structural features make it an invaluable intermediate for creating bioactive molecules with improved pharmacological properties. As research continues to uncover new applications for fluorinated amines, this compound is poised to play an increasingly important role in the discovery and design of next-generation therapeutics.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)